NASDAQ: INSM · Biotechnology
Over the past week, Insmed (INSM) pulled in about 38 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 44% bullish but is at odds: X runs 59% bullish while News sits at just 16%. Wall Street is more constructive, with 24 of 24 analysts rating INSM a buy.
There is little buzz around INSM this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 16% to X at 59%. No other tracker puts the two side by side.
24 analysts have weighed in: a Strong Buy consensus: 24 buy calls against 0 sell, with an average 12-month price target of $197.74.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 56 points above the crowd average of 44%, the professionals are more constructive than retail. The split is inside the crowd: X reads 59% bullish while News sits at 16%, a 43-point spread that single-source trackers miss.
Over the 30-day window, Insmed (INSM) buzz held subdued around 22.2 while the price drifted down 22.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.7M shares. Updated Oct 10, 2026. Over the last 7 trading days, INSM lost 7.4%. Buzz activity in the recent week averaged 30.5 and was relatively stable, swinging between 21.1 and 38.4. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 13 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for INSM and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live INSM sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (24 / 0 / 0) |
| Crowd bullish (7d) | 44% |
| Avg price target | $197.74 |
| Most bullish source | X, 59% |
| Most bearish source | News, 16% |
| Sentiment spread | 43 pts |
| Mentions (7d) | 38 |
| Market cap | $21.94B |
| P/E · Forward P/E | n/a · 97.1 |
| EPS · Beta | -$4.10 · 0.8 |
| Revenue (TTM) | $1.14B · -77% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Insmed (INSM) currently carries an Adanos hold signal with 66/100 conviction. The current cross-source average reads 44% bullish across 3 active sources. Those sources contribute 38 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Insmed (INSM) is fairly quiet with 7 mentions over the last 7 days; the 30-day context spans 5 tracked subreddits. The 7-day tone is 57% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Insmed (INSM), averaging 44% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 59% bullish and News at 16%, a 43-point spread. On the professional side, 24 of 24 analysts rate INSM a buy.
Of the 24 analysts covering Insmed (INSM), 24 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $197.74. That puts the street ahead of the crowd, which averages 44% bullish.
Insmed (INSM)'s cross-source average is bearish at 44% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. Reddit reads 57% bullish, X reads 59% bullish and news coverage is the most negative at 16% bullish. The combined signal points to broad mixed pressure with 66/100 conviction.
The cross-source average is bearish for Insmed (INSM) at 44% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is news at 16% bullish. 3-day activity momentum is falling on X, while news activity is rising. The hold signal carries 66/100 conviction.
News is the dominant discussion channel with 19 mentions (50% of total volume). X contributes 12 mentions and Reddit contributes 7 mentions. The cross-source average is bearish at 44% bullish, while news is the only source with rising 3-day activity. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. INSM's hold signal at 66/100 conviction reflects a bearish cross-source average at 44% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The INSM sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key